Maternal RSV Vaccinations
What is Respiratory Syncytial Virus (RSV)?
Respiratory syncytial virus (RSV) is a cold-like virus that infects the airways and lungs. It is one of the most common reasons for hospitalizations among young babies.
The RSV Maternal (MAT-004) Clinical Study
- Doctors and researchers want to learn whether the study vaccine is safe and helps create more germ-fighting antibodies in pregnant women and whether these antibodies are passed along to their babies.
- The study will take about 15 months to complete. It will begin in the third trimester of your pregnancy and will conclude when your baby is 12 months old.
- The study will enroll about 150 healthy pregnant women aged 18 to 40 years and their babies at clinical sites around the world.
Interested in Joining Us for this Study?
Talk with us and then your family about joining this study with your baby. You can also learn more by visiting www.rsvstudies.com/mat-004. Together, we can learn more about the potential to help prevent RSV disease among babies—now and in their future.